Gene · 6955
Papers2,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The case of T-ALL presenting with NK phenotype after COVID-19 vaccination. | Pathol Res Pract | 2023 | 36706586 | PubTator, text mining | PubMed |
| Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer. | Anticancer Res | 2023 | 36697107 | PubTator, text mining | PubMed |
| The use of non-functional clonotypes as a natural calibrator for quantitative bias correction in adaptive immune receptor repertoire profiling. | Elife | 2023 | 36692004 | PubTator, text mining | PubMed |
| How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors-An In Silico Screening Study. | Molecules | 2023 | 36677537 | PubTator, text mining | PubMed |
| BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures. | Int J Mol Sci | 2023 | 36674438 | PubTator, text mining | PubMed |
| Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators. | Biomedicines | 2023 | 36672685 | PubTator, text mining | PubMed |
| Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 36672325 | PubTator, text mining | PubMed |
| Tissue adaptation and clonal segregation of human memory T cells in barrier sites. | Nat Immunol | 2023 | 36658238 | PubTator, text mining | PubMed |
| Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis. | Nat Commun | 2023 | 36658110 | PubTator, text mining | PubMed |
| Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs. | Mol Ther Nucleic Acids | 2023 | 36618262 | PubTator, text mining | PubMed |
| The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer. | Immunity | 2023 | 36574773 | PubTator, text mining | PubMed |
| Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. | Clin Immunol | 2023 | 36539107 | PubTator, text mining | PubMed |
| Translational perspectives from TSHR, MCT8 and TRα research. | Nat Rev Endocrinol | 2023 | 36526876 | PubTator, text mining | PubMed |
| LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells. | Cancer Immunol Res | 2023 | 36484736 | PubTator, text mining | PubMed |
| Potential of TCR sequencing in graft-versus-host disease. | Bone Marrow Transplant | 2023 | 36477111 | PubTator, text mining | PubMed |
| T-cell and B-cell repertoire diversity are selectively skewed in children with idiopathic nephrotic syndrome revealed by high-throughput sequencing. | World J Pediatr | 2023 | 36449136 | PubTator, text mining | PubMed |
| Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors. | J Med Virol | 2023 | 36420584 | PubTator, text mining | PubMed |
| Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations. | Transl Res | 2023 | 36414227 | PubTator, text mining | PubMed |
| Organ-specific effects on target binding due to knockout of thyroid hormone receptor α during Xenopus metamorphosis. | Dev Growth Differ | 2023 | 36397722 | PubTator, text mining | PubMed |
| Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes. | Clin Cancer Res | 2023 | 36315045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6955/papers?page=17